The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer
Author:
Funder
Science and Technology Department, Henan Province
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference70 articles.
1. Cancer statistics;Siegel;CA Cancer J Clin,2019
2. Epidemiology of esophageal cancer;Zhang;World J Gastroenterol,2013
3. Interactions between genetic variants and environmental factors affect risk of esophageal adenocarcinoma and barrett's esophagus;Dong;Clin Gastroenterol Hepatol,2018
4. Integrated genomic characterization of oesophageal carcinoma;Kim;Nature,2017
5. Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial;Dutton;Lancet Oncol,2014
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Prognostic Signature of Cuproptosis-Related LncRNAs to Predict Survival and Immune Response in Esophageal Cancer;2024-01-09
2. Consensus Clustering Analysis Based on Enhanced-CT Radiomic Features: Esophageal Squamous Cell Carcinoma patients’ 3-Year Progression-Free Survival;Academic Radiology;2024-01
3. An update of Clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta- analysis;2023-09-18
4. TNFSF15 and MIA Variant Associated with Immunotherapy and Prognostic Evaluation in Esophageal Cancer;Journal of Oncology;2023-03-10
5. SPC25 Promotes the Proliferation and Migration of Esophageal Carcinoma by Activating the MAPK/ERK Pathway;Journal of Biomedical Nanotechnology;2023-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3